Pancuronium (bromide hydrate)

Pancuronium is an aminosteroid antagonist of muscle-type nicotinic acetylcholine receptors (nAChRs) with an IC₅₀ value of 14.8 nM using patch clamp electrophysiology in BOSC23 cells expressing mouse nAChRs. It acts as a non-depolarizing neuromuscular blocking agent. Pancuronium enhances anesthesia induced by isoflurane , reducing immobilization with an ED₅₀ value of 1.62 μg/kg.

[1] MAN LIU J P D. Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor.[J]. Molecular Pharmacology, 2009, 75 1: 166-173. DOI: 10.1124/mol.108.051060
[2] W R BUCKETT. The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent.[J]. British journal of pharmacology and chemotherapy, 1968, 32 3: 671-682. DOI: 10.1111/j.1476-5381.1968.tb00466.x
[3] YUSUKE MIYAZAKI. Pancuronium enhances isoflurane anesthesia in rats via inhibition of cerebral nicotinic acetylcholine receptors.[J]. Journal of Anesthesia, 2016, 30 4: 671-676. DOI: 10.1007/s00540-016-2178-1